There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Assessment of anti-inflammatory therapies against sulfur-mustard (bis(2-chloroethyl)sulfide,
HD)-induced skin injury has mainly relied on qualitative histopathological evaluation.
Development of quantifiable inflammatory biomarkers using fast and reliable molecular
methods is needed for screening anti-inflammatory drugs against HD injury. In this
study, we used two different HD exposure models to determine the in vivo cutaneous
response of the inflammatory cytokines interleukin-6 (IL-6), IL-1alpha, IL-1beta and
tumor necrosis factor alpha (TNF-alpha), in order to identify a suitable inflammatory
biomarker common to both models. In the first model, the backs of hairless mice were
exposed to HD vapor (1.4 g m(-3)) or sham controls for 6 min using an occluded vapor
cup technique. In the second model, right ears of CD1 mice were exposed to a solution
(5.0 microl of 195 mM) of HD (0.16 mg) in dichloromethane (CH2Cl2) whereas left ears
received only CH2Cl2 (vehicle control). Sulfur-mustard-induced skin inflammation was
assessed in skin punch specimens collected at time points up to 24 h post-exposure.
Edema was determined by measuring tissue weight, and cytokine content was measured
by enzyme immunosorbent assay. Characterized by an increase in edema and IL-6, HD
provoked a cutaneous inflammatory response in both models beginning at 6 h post-exposure
and continuing to 24 h. An increase in IL-1alpha was observed only in the hairless
mouse model, also beginning at 6 h post-exposure and continuing to 24 h. No IL-1beta
or TNF-alpha response was observed at any time point in either exposure model. These
data document the in vivo production of cutaneous IL-6, a distinct inflammatory biomarker,
in two different HD exposure models. We conclude that IL-6 should be a useful in vivo
biomarker for evaluating anti-inflammatory drugs against HD-induced skin injury.
Cutaneous exposure to sulfur mustard (bis(2-chloroethyl) sulfide, HD), a chemical warfare agent, produces a delayed inflammatory skin response and severe tissue injury. Despite defined roles of inflammatory cytokines produced or released in response to skin-damaging chemicals, in vivo cytokine responses associated with HD-induced skin pathogenesis are not well understood. Additionally, there is little information on the in vivo temporal sequence of gene expression of cytokines postexposure to HD. The goal of these studies was to identify in vivo molecular biomarkers of HD skin injury within 24 hours after HD challenge. Gene expression of interleukin 1beta (IL-1beta), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin 6 (IL-6), and interleukin 1alpha (IL-1alpha) in the mouse ear vesicant model was examined by quantitative reverse transcription-polymerase chain reaction (RT-PCR). An increase in IL-1beta mRNA levels was first observed at 3 hours. IL-1beta, GM-CSF, and IL-6 mRNA levels were dramatically increased at 6-24 hours postexposure. IL-1alpha mRNA levels were not increased following HD exposure. Immunohistochemical studies demonstrated that IL-1beta and IL-6 protein was produced at multiple sites within the ear, including epithelial cells, inflammatory cells, hair follicles, sebaceous glands, the dermal microvasculature, smooth muscle, and the dermal connective tissue. An increase in the intensity of staining for IL-1beta, and IL-6 was observed in localized areas at 6 hours and was evident in multiple areas at 24 hours. Positive staining for GM-CSF immunoreactive protein was localized to the inflammatory cells within the dermis. The number of immunostaining cells was increased as early as 1 hour following HD exposure. These studies document an early increase in the in vivo expression of inflammatory cytokines following cutaneous HD exposure. An understanding of the in vivo cytokine patterns following HD skin exposure may lead to defining the pathogenic mechanisms of HD injury and the development of pharmacological countermeasures.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.